
121 Lifescience Private Limited
About 121 Lifescience Private Limited
Data last updated:
121 Lifescience Private Limited is a private limited company based in Indore, Madhya Pradesh, India, a subsidiary of Microfab Engineering Solutions Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 October 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24290MP2021PTC058192.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹2 Cr. It is led by directors Hardeep Chawla and Meena Dheeman.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Khandelwall Compound 210/3/L Nemawar Road Palda, Indore, Madhya Pradesh, India – 452001.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.69 Lakh. For the same year it recorded a net loss of ₹1.89 Lakh (net margin -112%) and EBITDA of -₹1.89 Lakh (EBITDA margin -112%).
As per MCA filings, the company has open charges of ₹10 Cr on record.
Company details
Contact details
121 Lifescience Private Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressKhandelwall Compound 210/3/L Nemawar Road Palda, Indore, Madhya Pradesh, India – 452001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of 121 Lifescience Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of 121 Lifescience Private Limited
FY 2025 filings available121 Lifescience Private Limited reported revenue of ₹1.69 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹1.89 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹1.89 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -112% | |||
| Net Profit Margin | -112% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of 121 Lifescience Private Limited, buy the company report.
Board of directors of 121 Lifescience Private Limited
121 Lifescience has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hardeep Chawla Also directs: Dripcure Healthcare Private Limited, Singh Life Science Limited, Kar's Techno Plast Private Limited and 1 more | Director | 28 Oct 2021 | 5 Years 0 Months | Current |
| Meena Dheeman Also directs: Singh Life Science Limited, Kar's Techno Plast Private Limited | Director | 26 Dec 2025 | 0 Years 10 Months | Current |
Auditor
121 Lifescience Private Limited is audited by Piyush Chandra Mishra & Associates for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Piyush Chandra Mishra & Associates | FY 2022 | 013948C |
Shareholding
The shareholding of 121 Lifescience Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of 121 Lifescience Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Feb 2026 | 101247225 | Others | ₹10 Cr | Open |
To see the full charge records of 121 Lifescience Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving 121 Lifescience Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for 121 Lifescience Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for 121 Lifescience Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
121 Lifescience Private Limited has 3 board changes on record since 2021: 2 appointments and 1 cessation. The latest: Sajeev Tangaswami Nadar ceased to be Nominee Director on 05 Jan 2026.
Frequently asked questions
121 Lifescience is an active private limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 October 2021 (5+ years old) and is registered under CIN U24290MP2021PTC058192.
121 Lifescience has 2 current directors:
- Hardeep Chawla - Director
- Meena Dheeman - Director
The latest financial statements of 121 Lifescience on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of 121 Lifescience is U24290MP2021PTC058192. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
121 Lifescience was incorporated on 28 October 2021, making it 5+ years old. It is registered with the Registrar of Companies, Gwalior.
Sajeev Tangaswami Nadar ceased to be Nominee Director on 05 Jan 2026. Meena Dheeman was appointed as Director on 26 Dec 2025. Hardeep Chawla was appointed as Director on 28 Oct 2021.
The registered office of 121 Lifescience is at Khandelwall Compound 2103L Nemawar Road Palda, Indore, Madhya Pradesh, India – 452001.
121 Lifescience operates in the pharma industry, in the drug formulation and development segment.
121 Lifescience has open charges of ₹10 Cr and no satisfied charges on record as per latest MCA filings.
121 Lifescience can be reached at its registered office: Khandelwall Compound 2103L Nemawar Road Palda, Indore, Madhya Pradesh, India – 452001.

